Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
S | Common Stock | D | 2117 | $313.09 - $313.09 | $662,801 |
| 2024-05-02 | AMGEN INC | Santos Esteban
(EVP, Operations) |
F | Common Stock | D | 606 | $277.37 - $277.37 | $168,086 |
| 2024-05-02 | AMGEN INC | REESE DAVID M
(EVP & Chief Technology Officer) |
F | Common Stock | D | 650 | $277.37 - $277.37 | $180,290 |
| 2024-05-02 | AMGEN INC | Miller Derek
(SVP, Human Resources) |
F | Common Stock | D | 152 | $277.37 - $277.37 | $42,160 |
| 2024-05-02 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
F | Common Stock | D | 114 | $277.37 - $277.37 | $31,620 |
| 2024-05-02 | AMGEN INC | Griffith Peter H.
(EVP & CFO) |
F | Common Stock | D | 682 | $277.37 - $277.37 | $189,166 |
| 2024-05-02 | AMGEN INC | Graham Jonathan P
(EVP & Gen. Counsel & Secy.) |
F | Common Stock | D | 591 | $277.37 - $277.37 | $163,925 |
| 2024-05-02 | AMGEN INC | Gordon Murdo
(EVP, Global Commercial Ops) |
F | Common Stock | D | 758 | $277.37 - $277.37 | $210,246 |
| 2024-04-30 | AMGEN INC | Miller Derek
(SVP, Human Resources) |
F | Common Stock | D | 71 | $276.38 - $276.38 | $19,622 |
| 2024-04-30 | AMGEN INC | Khosla Rachna
(SVP, Business Development) |
F | Common Stock | D | 48 | $276.38 - $276.38 | $13,266 |
| 2024-04-30 | AMGEN INC | Graham Jonathan P
(EVP & Gen. Counsel & Secy.) |
F | Common Stock | D | 686 | $276.38 - $276.38 | $189,596 |
| 2024-04-30 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
F | Common Stock | D | 106 | $276.38 - $276.38 | $29,296 |
| 2024-04-30 | AMGEN INC | Santos Esteban
(EVP, Operations) |
F | Common Stock | D | 683 | $276.38 - $276.38 | $188,767 |
| 2024-04-30 | AMGEN INC | REESE DAVID M
(EVP & Chief Technology Officer) |
F | Common Stock | D | 690 | $276.38 - $276.38 | $190,702 |
| 2024-04-30 | AMGEN INC | Griffith Peter H.
(EVP & CFO) |
F | Common Stock | D | 603 | $276.38 - $276.38 | $166,657 |
| 2024-04-30 | AMGEN INC | Gordon Murdo
(EVP, Global Commercial Ops) |
F | Common Stock | D | 753 | $276.38 - $276.38 | $208,114 |
| 2024-04-30 | AMGEN INC | Busch Matthew C.
(VP, Finance & CAO) |
F | Common Stock | D | 17 | $276.38 - $276.38 | $4,698 |
| 2024-04-30 | AMGEN INC | Bradway Robert A
(Chairman, CEO and President) |
F | Common Stock | D | 2282 | $276.38 - $276.38 | $630,699 |
| 2024-03-18 | AMGEN INC | Santos Esteban
(EVP, Operations) |
F | Common Stock | D | 6137 | $268.87 - $268.87 | $1,650,055 |
| 2024-03-18 | AMGEN INC | REESE DAVID M
(EVP & Chief Technology Officer) |
F | Common Stock | D | 6202 | $268.87 - $268.87 | $1,667,531 |
| 2024-03-18 | AMGEN INC | Miller Derek
(SVP, Human Resources) |
F | Common Stock | D | 475 | $268.87 - $268.87 | $127,713 |
| 2024-03-18 | AMGEN INC | Khosla Rachna
(SVP, Business Development) |
F | Common Stock | D | 438 | $268.87 - $268.87 | $117,765 |
| 2024-03-18 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
F | Common Stock | D | 703 | $268.87 - $268.87 | $189,015 |
| 2024-03-18 | AMGEN INC | Griffith Peter H.
(EVP & CFO) |
F | Common Stock | D | 5168 | $268.87 - $268.87 | $1,389,520 |
| 2024-03-18 | AMGEN INC | Graham Jonathan P
(EVP & Gen. Counsel & Secy.) |
F | Common Stock | D | 5879 | $268.87 - $268.87 | $1,580,686 |
| 2024-03-18 | AMGEN INC | Gordon Murdo
(EVP, Global Commercial Ops) |
F | Common Stock | D | 6461 | $268.87 - $268.87 | $1,737,169 |
| 2024-03-18 | AMGEN INC | Busch Matthew C.
(VP, Finance & CAO) |
F | Common Stock | D | 146 | $268.87 - $268.87 | $39,255 |
| 2024-03-18 | AMGEN INC | Bradway Robert A
(Chairman, CEO and President) |
F | Common Stock | D | 20560 | $268.87 - $268.87 | $5,527,967 |
| 2024-03-06 | AMGEN INC | Santos Esteban
(EVP, Operations) |
A | Common Stock | A | 12278 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | REESE DAVID M
(EVP & Chief Technology Officer) |
A | Common Stock | A | 12407 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Miller Derek
(SVP, Human Resources) |
A | Common Stock | A | 1311 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Khosla Rachna
(SVP, Business Development) |
A | Common Stock | A | 1256 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
A | Common Stock | A | 1954 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Griffith Peter H.
(EVP & CFO) |
A | Common Stock | A | 10338 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Graham Jonathan P
(EVP & Gen. Counsel & Secy.) |
A | Common Stock | A | 11760 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Gordon Murdo
(EVP, Global Commercial Ops) |
A | Common Stock | A | 12924 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Busch Matthew C.
(VP, Finance & CAO) |
A | Common Stock | A | 418 | $0.00 - $0.00 | $0 |
| 2024-03-06 | AMGEN INC | Bradway Robert A
(Chairman, CEO and President) |
A | Common Stock | A | 41133 | $0.00 - $0.00 | $0 |
| 2024-02-09 | AMGEN INC | Bradner James E.
(EVP, R&D, & Chief Sci. Officer) |
A | Common Stock | A | 22393 | $0.00 - $0.00 | $0 |
| 2023-11-08 | AMGEN INC | Graham Jonathan P
(EVP, Gen. Counsel & Secy.) |
S | Common Stock | D | 10000 | $272.81 - $272.81 | $2,728,136 |
| 2023-11-05 | AMGEN INC | Miller Derek
(SVP, Human Resources) |
F | Common Stock | D | 66 | $269.86 - $269.86 | $17,810 |
| 2023-11-05 | AMGEN INC | Khosla Rachna
(SVP, Business Development) |
F | Common Stock | D | 317 | $269.86 - $269.86 | $85,544 |
| 2023-11-05 | AMGEN INC | Grygiel Nancy A.
(SVP & CCO) |
F | Common Stock | D | 249 | $269.86 - $269.86 | $67,195 |
| 2023-11-05 | AMGEN INC | Busch Matthew C.
(VP, Finance & CAO) |
F | Common Stock | D | 249 | $269.86 - $269.86 | $67,194 |
| 2023-11-03 | AMGEN INC | ISHRAK OMAR
(Director) |
A | Common Stock | A | 240 | $0.00 - $0.00 | $0 |
| 2023-11-03 | AMGEN INC | HOLLEY CHARLES M
(Director) |
A | Common Stock | A | 296 | $0.00 - $0.00 | $0 |
| 2023-11-03 | AMGEN INC | Drake Michael V
(Director) |
A | Common Stock | A | 240 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |